In the present study, we compared effector functions and performed phenotypic analysis of MSLN-CAR T cells containing either a CD28 (M28z) or 4–1BB (MBBz) co-stimulatory domain in different in vitro models of ovarian cancer. This evidence concerns the gene CD28 and ovarian cancer.